Table 5.
Comparison between NP and non-NP patients.
| NP | Non-NP | ||
|---|---|---|---|
| n = 33 | n = 68 | P- value | |
| Age, years | |||
| Median (IQR) | 69 (60.5–74.5) | 68.5 (58–75.8) | 0.622 |
| Sex, number | |||
| Male | 22 | 44 | 0.846 |
| ECOG Performance Status Scale | |||
| Median | 3 | 3 | 0.882 |
| Survival time, days | |||
| Median (IQR) | 40 (17–69.5) | 32.5 (15.3–56.5) | 0.377 |
| Mean (SD) | 47.3 (34.6) | 41.4 (32.6) | |
| Pain therapy | |||
| Opioids, number (%) | 21 (63.6) | 44 (64.7) | 0.916 |
| Coanalgesics, number (%) | 9 (27.3) | 1 (1.5) | <.001 |
| Equivalent oral morphine dose, mg | |||
| Median (IQR) | 23 (0–40) | 15 (0–50) | 0.897 |
| History of chemotherapy and/or biologic treatment, number (%) | |||
| 26 (78.8) | 57 (83.8) | 0.535 | |
| NRS score | |||
| Median (IQR) | 7 (5.5–8) | 5 (4–8) | 0.025 |
| Pain type, number (%) | |||
| Somatic pain | 22 (66.7) | 15 (22.1) | <.001 |
| Visceral pain | 3 (9.1) | 29 (42.6) | <.001 |
| Somatic and visceral pain | 8 (24.2) | 24 (35.3) | 0.256 |
| Pure NP | 0 (0) | ||
ECOG, Eastern Cooperative Oncology Group; IQR, interquartile range; NP, neuropathic pain; NRS, numerical rating scale; SD, standard deviation.